Motif Bio Share Discussion Threads

[timw3] 05/2/2018 20:33

dow crashing. see this going below 30p soon. ugly chart also

[gersemi] 03/2/2018 08:38

From today's Interactive ---- Investor site
Motif Bio (MTFB)

37.55p

Antibiotics developer Motif Bio (MTFB) is reaching an important point in the development of its new antibiotic Iclaprim, which is focused on acute bacterial skin and skin structure infections (ABSSSI). Antibiotic resistance is a key topic in the healthcare sector so new antibiotics are essential.

Iclaprim was originally discovered by Hoffman-La Roche, but Motif has adapted the development programme to address the reasons it failed to gain FDA approval in 2009.

Iclaprim has shown that it is at least as good as existing antibiotics in treating skin infections, but without the side effects of the rivals. It can be used on very sick patients.

The plan is to lodge a new drug application in the US during the first quarter of 2018. If things go smoothly, then there could be a commercial treatment by the end of 2018.

Motif has secured a $20 million loan facility, which more than doubled the available cash. A shelf registration in the US will enable Motif, which is also listed on Nasdaq, to raise up to $80m over a three-year period, although it says that no fundraising is currently planned.

The US hospital market will be targeted via a contract sales organisation, while in Europe a partner will be sought and they will provide milestone payments to help to finance the approvals process in the region.

Moving towards approvals that confirm that Iclaprim is a commercial product should propel the share price upwards.

-

[flavio_monteiro] 02/2/2018 21:03

MTFB 36p on AIM....equivalent 40p Finish on Nasdaq....

[small crow] 02/2/2018 20:42

Normally means sacked!

[waterloo01] 02/2/2018 18:05

Never ideal if the CFO leaves and they don;t state why.

[librayang0925] 01/2/2018 07:59

I remember seeing several 70000ish buys as well

[small crow] 31/1/2018 18:09

It's not really that big is it. And the other?

[librayang0925] 31/1/2018 17:42

One with about 140000 shares

[librayang0925] 31/1/2018 15:25

Two very big buys

[waterloo01] 30/1/2018 08:01

To be published later today some improvement in incentives for developing antibiotics

[flavio_monteiro] 27/1/2018 10:45

It’s quiet as we private investors are selling and Merrill Lynch a huge institutional are buying and increasing their holding. See recent holding RNS.

[librayang0925] 27/1/2018 10:14

This board is quiet

[chadders] 22/1/2018 22:52

Sorry chaps wrong board

[escapetohome] 22/1/2018 20:12

Pj , everything is a POS if you buy too high!

[longshanks] 22/1/2018 17:36

Short it PJJ - you'll be happier with it and yourself

[pjj71] 22/1/2018 14:57

what a POS this is turning out to be...

[pyglet] 19/1/2018 08:38

Brilliant opportunity to top up

[waterloo01] 19/1/2018 08:26

It's required as they have to notify Nasdaq of the filing and as such inform AIM.

[wilmot] 19/1/2018 08:23

I don't understand why they bothered to RNS it unless its a requirement which I don't think it is. it just seems to be admin. The market will assume a dilution is on the way.

[longshanks] 19/1/2018 08:22

Slightly predictable yet ridiculous market response to the shelf announcement.The news only declares that should they wish to, they will be in a position to raise money on NASDAQ at some time in the future in an easier fashion.Looks to me like yet another fishing expedition for stops before allowing the next wave up to 45p. Pathetic really.

[waterloo01] 19/1/2018 08:16

I think folk are misinterpreting the shelf filling, which is standard on Nasdaq. It means as and when they need another round of cash, it's much quicker and easier to raise it. Doesn't mean they will raise pre results nor the price, which would be determined at the time (which could be anytime within 3 years).

It strengthens their hand as and when they are negotiating with potential partners.

[encarter] 19/1/2018 08:02

That will depend on the share price at that time.

[adorling] 19/1/2018 07:55

Agree that it indicates further US capital raising but at what price?

[gersemi] 19/1/2018 07:33

That's a very interesting development. It points to a possible, future commercial event(s) that may need funding. It is a positive for the company and indeed its valuation